Chengdu B-Ray Media Co.Ltd(600880) : the intended investor of roaming Valley’s capital and share increase is Shanghai magic power
Chengdu B-Ray Media Co.Ltd(600880) it was announced that the capital increase and share expansion of Beijing roaming Valley Information Technology Co., Ltd. (hereinafter referred to as “roaming Valley”), a wholly-owned subsidiary of the company, had been listed on the southwest stock exchange. During the announcement period, Shanghai magic Information Technology Co., Ltd., an intended investor, submitted application materials and paid a full margin. Roaming Valley has reviewed the registration materials of Shanghai magic power and confirmed that it is qualified for investment. Therefore, the intended investor of roaming Valley’s capital and share increase is Shanghai magic power.
Kangmei Pharmaceutical Co.Ltd(600518) : the implementation of the reorganization plan is completed
Kangmei Pharmaceutical Co.Ltd(600518) announced that the company recently received the civil ruling of the court, which confirmed that the reorganization plan has been implemented. After the implementation of the restructuring plan, with the resolution of the debt crisis and the support of investors, the company will gradually restore its sustainable operation ability and profitability and return to the benign development track, which will also have a positive impact on the company’s net assets and net profits in 2021.
Zhejiang Medicine Co.Ltd(600216) it is proposed to invest 620 million yuan in the industrialization project of 600000 bottles of recombinant humanized anti-HER2 monoclonal antibody as269 coupling preparation per year
Zhejiang Medicine Co.Ltd(600216) it is announced that the holding subsidiary of the company, xincode biology, plans to invest in the industrialization project of xincode biology with an annual output of 600000 bottles of recombinant humanized anti-HER2 monoclonal antibody-as269 coupling preparation, in order to achieve the goal of the company’s “14th five year plan”, build xincode biology into a modern antibody coupling drug company integrating R & D, clinical and production, and reduce production costs, Adapt to the overall requirements of medical insurance fee reduction in the future, and promote the rapid development and growth of new code biology. The total investment of the project is planned to be 620 million yuan.
Beijing Tieke Shougang Railway-Tech Co.Ltd(688569) sign 449 million yuan project contract with Chengdu Lanzhou Railway
It is announced that recently, the company signed a project contract with Chengdu Lanzhou Railway Co., Ltd. to supply high-speed railway buckle accessories. The total contract amount is 448.727 million yuan (including tax), and the amount excluding tax is 397.1035 million yuan, accounting for 32.30% of the company’s audited operating revenue in 2020.
Harbin Viti Electronics Corp(603023) it is proposed to establish a joint venture to develop the main engine market of special vehicles
Harbin Viti Electronics Corp(603023) it is announced that the company plans to jointly invest with Hangzhou xunma Machinery Co., Ltd. and Shanghai Furui Hill Automotive Technology Co., Ltd. to establish a joint venture and cooperation project with forklift axle, central control electronic instrument and vehicle electronic components as the core, and plans to establish a joint venture in Lishui Economic and Technological Development Zone, Zhejiang Province, with a registered capital of 55 million yuan and a 55% shareholding of the company. As the forerunner for the company to enter the main engine market of special vehicles, the project will try to open up the axle and central control electronic host market of special vehicles and commercial vehicles for various purposes, so as to bring greater market space for the company.
Sichuan Expressway Company Limited(601107) : the company’s main business does not involve digital currency related business and there is no relevant investment plan
Sichuan Expressway Company Limited(601107) issue a stock trading risk warning announcement. The company has recently paid attention to media reports and Internet stock bar rumors that the company has participated in digital currency and related businesses. After verification, as of the date of this announcement, the company’s main business does not involve digital currency related businesses and there is no relevant investment plan. More than 5% of the companies controlled and participated in by the company have not directly or indirectly participated in digital currency and related businesses.
In addition, some media reports and Internet stock bars believe that the company is a hot concept stock of venture capital. After verification, as of the date of this announcement, the company within the scope of the company’s consolidated statements does not involve venture capital business and has no relevant investment plan; The company’s joint venture Sichuan Expressway Company Limited(601107) development equity investment fund center (limited partnership) (hereinafter referred to as “Chengdu Chongqing Development Fund”) involves venture capital business, but the company does not control Chengdu Chongqing Development Fund, and venture capital business is not the company’s main business. Please pay attention to the transaction risks in the secondary market, make rational decisions and invest prudently.
Star Lake Bioscience Co.Inc.Zhaoqing Guangdong(600866) : at present, there is no intermediate product related to carbonic anhydride and ritonavir
Star Lake Bioscience Co.Inc.Zhaoqing Guangdong(600866) issue a stock trading announcement. At present, the company does not produce intermediate products related to carbonic anhydride and ritonavir, and the main business and product structure have not changed significantly.
Shinva Medical Instrument Co.Ltd(600587) plans to acquire the remaining 40% equity of Xinhua surgical instruments
Shinva Medical Instrument Co.Ltd(600587) it is announced that the company plans to acquire 40% equity of Xinhua surgical instruments Co., Ltd. (hereinafter referred to as “Xinhua surgical instruments”) held by German snake company on the basis of RMB 48.195 million and after deducting relevant taxes and fees that should be withheld and remitted, and convert the corresponding Euro according to the foreign exchange rate published by the people’s Bank of China on the day of payment. As the starting product of Shinva Medical Instrument Co.Ltd(600587) , Xinhua surgical instruments have advanced technology and complete product types, which are widely recognized by clinical and customers. After the acquisition, Xinhua surgical instruments will become a wholly-owned subsidiary of the company.
Foshan Haitian Flavouring And Food Company Ltd(603288) it is proposed to invest 525 million yuan in Haitian Brewing Food Co., Ltd. and Zhejiang Jiusheng Oil Tea Technology Co., Ltd.
Foshan Haitian Flavouring And Food Company Ltd(603288) announced that the company plans to invest 50 million yuan to establish a wholly-owned subsidiary Haitian Brewing Food Co., Ltd. in Guangzhou; Daidaitian (Wuhan) Food Group Co., Ltd., a wholly-owned subsidiary, intends to acquire part of the existing shareholders’ equity of Zhejiang Jiusheng Camellia Oil Technology Co., Ltd. and unilaterally increase the capital of Zhejiang Jiusheng Camellia Oil Technology Co., Ltd. after the transfer and capital increase, daidaidaitian (Wuhan) Food Group Co., Ltd. will hold 67% of the equity of Zhejiang Jiusheng Camellia Oil Technology Co., Ltd, The registered capital of Zhejiang Jiusheng Oil Tea Technology Co., Ltd. was changed from 50.25 million yuan to 98.98 million yuan, and the total amount of the above transactions was 475.09 million yuan.
Yuanli Chemical Group Co.Ltd(603217) it is proposed to invest 3 billion yuan in projects such as hindered amine light stabilizer and diol
Yuanli Chemical Group Co.Ltd(603217) it is announced that the company has signed a project investment agreement with Shandong Changyi economic development zone through its wholly-owned subsidiary Chongqing Yuanli, and plans to invest in the construction of hindered amine light stabilizers, diols and other projects in Changyi Xiaying Chemical Industrial Park. The total investment of the project is about 3 billion yuan, of which the fixed asset investment is expected to be 2.1 billion yuan. The project is invested and constructed in two phases.
The company announced on the same day that it plans to invest in the construction of a 60000 ton annual output of dimethyl dicarboxylate project, with an estimated total investment of 300 million yuan. The company said that the company currently has an annual production capacity of 100000 tons of dimethyl dicarboxylate, accounting for more than 50% of the market. In addition, the company has formed a relatively complete industrial chain system of dimethyl dicarboxylate products, and newly invested in the construction of 60000 T / a dimethyl dicarboxylate project, which is conducive to improving the product market supply and further opening up greater growth space.
Shinva Medical Instrument Co.Ltd(600587) it is proposed to raise no more than RMB 1.284 billion, and the controlling shareholder intends to participate in the subscription of
Shinva Medical Instrument Co.Ltd(600587) announced that the company plans to issue shares in a non-public manner, raising no more than 1283564300 yuan. After deducting the issuance expenses, it plans to be used for intelligent manufacturing and supporting projects based on flexible processing production line, high-end precision minimally invasive surgical instrument production expansion project, pharmaceutical small capacity preparation intelligent production equipment industrialization project, Shinva Medical Instrument Co.Ltd(600587) high-end medical equipment R & D inspection and testing center project Industrialization construction project of high-performance radiotherapy equipment and medical imaging products, industrialization project of laboratory series products and supplementary working capital. Shandong health, the controlling shareholder of the company, intends to participate in this subscription, and the number of shares subscribed shall not be less than 28.77% of the total number of shares issued this time.
Beijing Aerospace Changfeng Co.Ltd(600855) it is proposed to jointly develop ECMO complete equipment with the controlling shareholder
Beijing Aerospace Changfeng Co.Ltd(600855) announced that the company signed a joint development contract for “research and development of cardiopulmonary bypass equipment with extracorporeal life support” with the controlling shareholder Electromechanical institute (Defense Institute) in Beijing on December 31, 2021. The two sides jointly developed “cardiopulmonary bypass equipment with extracorporeal life support”. The total amount of the joint development contract is 41.65 million yuan, of which Beijing Aerospace Changfeng Co.Ltd(600855) bears the research and development fund of 4.15 million yuan and the Electromechanical institute bears the research and development fund of 37.5 million yuan. After the R & D content is completed, the equipment is owned by Beijing Aerospace Changfeng Co.Ltd(600855) and one set of ECMO host is completed for the verification of core key technologies; The technical data shall be jointly owned by the Electromechanical institute and Beijing Aerospace Changfeng Co.Ltd(600855) both parties, and the intellectual property (patent) shall be registered in the names of both parties.
According to the announcement, extracorporeal life support cardiopulmonary bypass equipment (also known as ECMO, extracorporeal membrane pulmonary oxygenation) plays a key role in the treatment of patients with cardiopulmonary failure and is outstanding in the treatment of “covid-19” critically ill patients with pneumonia. With the aggravation of aging, the number of critical cases relying on ECMO is increasing rapidly. At present, China has no domestic products, and equipment and consumables are heavily dependent on imports; The incidence of bleeding / thrombosis and other complications in the clinical use of existing imported products is high; The device is complicated, inconvenient to use, difficult to operate and manage, and limited in clinical indications and application scenarios. Therefore, the independent research and development of high-performance ECMO system not only has strategic significance, but also has broad market prospects.
Jiangsu High Hope International Group Corporation(600981) it is proposed to transfer 100% equity and related creditor’s rights of Boyi company
Jiangsu High Hope International Group Corporation(600981) announced that in order to further focus on the company’s main business and optimize resource allocation, Huihong Zhongjin, the holding subsidiary of the company, plans to transfer 100% equity of Jiangsu Boyi Investment Management Co., Ltd. (hereinafter referred to as “Boyi company”) and Huihong Zhongjin’s creditor’s rights of 61.3135 million yuan to Boyi company to jinzhongjin through non-public agreement. The equity transfer price is 29.75 million yuan, the debt transfer price is 61.3135 million yuan, and the total transaction price is 91.0635 million yuan. The counterparty Jin Zhongjin is a subsidiary of Suhui asset management, the controlling shareholder of the company.
The subsidiary of Shandong Shida Shenghua Chemical Group Company Limite(603026) plans to invest in the 40000 t / a battery grade vinyl carbonate refining project
Shandong Shida Shenghua Chemical Group Company Limite(603026) announced that Shandong Shida Shenghua Chemical Group Company Limite(603026) (Quanzhou) Co., Ltd., the holding subsidiary of the company, plans to invest in the 40000 t / a battery grade vinyl carbonate refining project. The total investment of the project is expected to be 16.1 million yuan. The construction site of the project is QUANHUI Petrochemical Park, Hui’an County, Quanzhou City, Fujian Province. It is expected to be completed and put into operation in May 2022. The company said that up to now, the construction of 120000 T / a vinyl carbonate unit has been completed. The main purpose of the project is to purify 40000 t / a industrial vinyl carbonate into battery grade vinyl carbonate products, and the total capacity remains unchanged.
Qingdao Gaoce Technology Co.Ltd(688556) sign the sales contract of 146 million yuan photovoltaic cutting equipment
Qingdao Gaoce Technology Co.Ltd(688556) announced that the company recently signed an equipment sales contract with Guangdong Jinwan Gaojing Cecep Solar Energy Co.Ltd(000591) Technology Co., Ltd. The subject matter of the contract is photovoltaic cutting equipment, and the contract amount is 145.72 million yuan (including tax). This contract is the company’s product sales contract. The supplier shall deliver the goods to the place designated by the demander in batches before March 2022; The installation, commissioning, acceptance and quality assurance of the goods have been completed. If the contract is successfully performed, it is expected to have a positive impact on the company’s operating performance in 2022.
Holsin Engineering Consulting Group Co.Ltd(603909) controlling shareholders increase their holdings of 4.50% of the company’s shares
According to the announcement of Holsin Engineering Consulting Group Co.Ltd(603909) , Xiamen Yiyue, the controlling shareholder, increased 9023752 shares of the company from December 27 to December 29, 2021, accounting for about 4.50% of the total share capital of the company. After this equity change, the shareholding ratio of Xiamen Yiyue reached 29.01%. In the next six months, Xiamen Yiyue has no subsequent shareholding increase plan.
Zhejiang Hangke Technology Incorporated Company(688006) it is proposed to raise no more than 2.312 billion yuan
Zhejiang Hangke Technology Incorporated Company(688006) it is announced that the company plans to issue shares in a non-public manner, with a total fund-raising of no more than 2311676200 yuan. After deducting the issuance expenses, it plans to be used for the construction project of intelligent manufacturing of lithium-ion battery charging and discharging equipment, the technical transformation project of production intelligence and information improvement, the overseas business network layout and the construction project of basic R & D and assembly manufacturing center, and supplement working capital.
Guizhou Wire Rope Co.Ltd(600992) clarify that the rumors about “backdoor of liquor enterprises” are not true
Guizhou Wire Rope Co.Ltd(600992) issued the announcement of stock trading changes. The company was concerned about the rumors about the company’s “backdoor of liquor enterprises”. The company conducted a comprehensive investigation and consulted the controlling shareholders and actual controllers. The company is not involved in the negotiation or negotiation of “backdoor” and “reorganization” with wine enterprises, nor does it plan to engage in wine related business. The rumors about the company’s “backdoor of wine enterprises” are untrue.
Crrc Corporation Limited(601766) signed a total contract of about 21 billion yuan from October to December
Crrc Corporation Limited(601766) announced that the company signed several contracts from October to December 2021, with a total amount of about 21 billion yuan, accounting for about 9.2% of the company’s operating revenue in 2020.
Nanjing Chervon Auto Precision Technology Co.Ltd(603982) to sell transmission case to Chongqing Qingshan
Nanjing Chervon Auto Precision Technology Co.Ltd(603982) it is announced that recently, Chongqing Qingshan Industry Co., Ltd. (hereinafter referred to as “Chongqing Qingshan”) has received a fixed-point notice of the project. Chongqing Qingshan plans to purchase transmission box from the company for terminal assembly of Changan’s models. It is estimated that the project amount is 1.7 billion yuan and the project implementation cycle is expected to be 5 years.
Hunan Changyuan Lico Co.Ltd(688779) it is proposed to invest 2.088 billion in the project of lithium iron phosphate cathode material with an annual output of 60000 tons
Hunan Changyuan Lico Co.Ltd(688779) announced that the company plans to expand the lithium iron phosphate cathode material business on the basis of the existing ternary cathode material and lithium cobalt oxide cathode material business. Hunan Hunan Changyuan Lico Co.Ltd(688779) new energy Co., Ltd., a wholly-owned subsidiary of the company, plans to invest in the construction of a 60000t / a lithium iron phosphate cathode material project, with a total investment of about 2087886800 yuan.
Xtc New Energy Materials( Xiamen) Co.Ltd(688778) it is proposed to purchase 40000-70000 tons of ternary precursor from PavA shares
Xtc New Energy Materials( Xiamen) Co.Ltd(688778) it is announced that the company and Zhejiang PavA new energy Co., Ltd. (hereinafter referred to as “PavA”) signed the strategic cooperation framework agreement on December 30, 2021. From January 1, 2022 to December 31, 2024, PavA shares is expected to supply 40000-70000 tons of ternary precursors to Xtc New Energy Materials( Xiamen) Co.Ltd(688778) , which shall be subject to the purchase and sales contract, processing contract and purchase and sales order actually signed by both parties. Pawa Co., Ltd. is a national high-tech enterprise focusing on the R & D, production and sales of ternary cathode material precursors for lithium-ion batteries for electric vehicles.
The subsidiary of Dongfeng Electronic Technology Co.Ltd(600081) plans to sign a technical service agreement to increase the net profit by 40 million yuan in advance
Dongfeng Electronic Technology Co.Ltd(600081) announcement: in order to ensure the smooth implementation of the localization of Epower electric drive system, Wuhan electric drive company and Dongfeng die casting company under the company intend to sign the technical service framework agreement for l21be-power localization project with Dongfeng parts, the controlling shareholder of the company. All parties agree on the production preparation expenses incurred in l21b-epower project through consultation, Special epidemic expenses and financial expenses shall be paid to the localization undertaker at one time. This transaction is expected to increase the net profit attributable to the shareholders of the listed company in the consolidated statements of the company in 2021 by about 40 million yuan.
Sichuan Xichang Electric Power Co.Ltd(600505) intends to acquire 39% equity of Fengguang new energy company
Sichuan Xichang Electric Power Co.Ltd(600505) announced that the company plans to acquire 39% equity of Yanyuan Fengguang new energy Co., Ltd. held by Sichuan Zhonghuan Energy Co., Ltd. for 48.47 million yuan. After the acquisition, the equity structure of Fengguang company is: the company holds 90% and Yanyuan Jintie Mining Group Co., Ltd. holds 10%. The target company of this acquisition is a holding subsidiary of the company, which will not change the scope of the company’s consolidated statements.
Nantong Jiangshan Agrochemical & Chemicals Co.Ltd(600389) shareholders plan to reduce their holdings of no more than 6% of the company’s shares
Nantong Jiangshan Agrochemical & Chemicals Co.Ltd(600389) announced that Fuhua technology, a shareholder with a shareholding of 27.19%, plans to reduce its total shares of the company by means of centralized bidding and block trading, which shall not exceed 6% of the total share capital of the company.
(Shanghai Securities News · China Securities Network)
